Evolent Health (Germany) Performance
| 9EH Stock | EUR 10.80 0.40 3.85% |
The firm shows a Beta (market volatility) of -0.61, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Evolent Health are expected to decrease at a much lower rate. During the bear market, Evolent Health is likely to outperform the market. At this point, Evolent Health has a negative expected return of -1.27%. Please make sure to confirm Evolent Health's jensen alpha, treynor ratio, and the relationship between the information ratio and total risk alpha , to decide if Evolent Health performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Evolent Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 354.9 M |
Evolent |
Evolent Health Relative Risk vs. Return Landscape
If you would invest 2,720 in Evolent Health on September 13, 2024 and sell it today you would lose (1,680) from holding Evolent Health or give up 61.76% of portfolio value over 90 days. Evolent Health is currently producing negative expected returns and takes up 6.1238% volatility of returns over 90 trading days. Put another way, 54% of traded stocks are less volatile than Evolent, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Evolent Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Evolent Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Evolent Health, and traders can use it to determine the average amount a Evolent Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2076
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 9EH |
Estimated Market Risk
| 6.12 actual daily | 54 54% of assets are less volatile |
Expected Return
| -1.27 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.21 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Evolent Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Evolent Health by adding Evolent Health to a well-diversified portfolio.
Evolent Health Fundamentals Growth
Evolent Stock prices reflect investors' perceptions of the future prospects and financial health of Evolent Health, and Evolent Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Evolent Stock performance.
| Return On Equity | -0.0241 | |||
| Return On Asset | 0.002 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | 0 % | |||
| Current Valuation | 3.01 B | |||
| Shares Outstanding | 111.05 M | |||
| Price To Book | 3.31 X | |||
| Price To Sales | 2.16 X | |||
| Revenue | 1.35 B | |||
| EBITDA | 20.69 M | |||
| Cash And Equivalents | 172.86 M | |||
| Cash Per Share | 2.11 X | |||
| Total Debt | 215.68 M | |||
| Debt To Equity | 24.60 % | |||
| Book Value Per Share | 8.60 X | |||
| Cash Flow From Operations | (11.55 M) | |||
| Earnings Per Share | (0.19) X | |||
| Total Asset | 1.82 B | |||
About Evolent Health Performance
By analyzing Evolent Health's fundamental ratios, stakeholders can gain valuable insights into Evolent Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Evolent Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Evolent Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia. EVOLENT HEALTH operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3800 people.Things to note about Evolent Health performance evaluation
Checking the ongoing alerts about Evolent Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Evolent Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Evolent Health generated a negative expected return over the last 90 days | |
| Evolent Health has high historical volatility and very poor performance | |
| The company reported the revenue of 1.35 B. Net Loss for the year was (19.16 M) with profit before overhead, payroll, taxes, and interest of 316.58 M. | |
| Evolent Health has accumulated about 172.86 M in cash with (11.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.11. | |
| Over 93.0% of the company shares are owned by institutions such as pension funds |
- Analyzing Evolent Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Evolent Health's stock is overvalued or undervalued compared to its peers.
- Examining Evolent Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Evolent Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Evolent Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Evolent Health's stock. These opinions can provide insight into Evolent Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Evolent Stock analysis
When running Evolent Health's price analysis, check to measure Evolent Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolent Health is operating at the current time. Most of Evolent Health's value examination focuses on studying past and present price action to predict the probability of Evolent Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolent Health's price. Additionally, you may evaluate how the addition of Evolent Health to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |